A decade after gene therapy, children born with deadly immune disorder remain healthy
Over a decade ago, UCLA physician-scientists began using a pioneering gene therapy they developed to treat children born with a rare and deadly immune system disorder.They now report that the effects of the therapy appear to be long-lasting, with 90% of patients who received the treatment eight to 11 years ago still disease-free.ADA-SCID, oradenosine deaminase –deficient severe combined immunodeficiency, is caused by mutations in the gene that creates the ADA enzyme, which is essential to a functioning immune system. For babies with the disease, exposure to everyday germs can be fatal, and if untreated, most will die...
Source: UCLA Newsroom: Health Sciences - October 15, 2021 Category: Universities & Medical Training Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Media News - October 13, 2021 Category: Pharmaceuticals Source Type: news

Data up to 8-years for Roche ’s OCREVUS (ocrelizumab) show early and ongoing treatment significantly reduced risk of requiring a walking aid in relapsing multiple sclerosis and disability progression in primary progressive multiple sclerosis
Basel, 13 October 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data that reinforce the benefit of early initiation and ongoing treatment of OCREVUS® (ocrelizumab) on disability progression in relapsing multiple sclerosis (RMS) and primary progressive MS (PPMS), as well as safety outcomes for an analysis of shorter 2-hour infusion in minority populations. OCREVUS data from all clinical trials consistently show a favourable benefit-risk profile over eight years. Roche and research partners will also present four late-breaking abstracts to share the latest data regarding COVID-19 and vacci...
Source: Roche Investor Update - October 13, 2021 Category: Pharmaceuticals Source Type: news

Hair loss: Significant factor 'impairs hair follicle stem cells' – and we are all at risk
HAIR is viewed as the epitome of youthfulness - a full-bodied mane is not only desirable, it can help improve self esteem and self confidence. But is yours falling short? (Source: Daily Express - Health)
Source: Daily Express - Health - October 8, 2021 Category: Consumer Health News Source Type: news

20 cases of bacterial infection linked to use of unapproved stem cell therapies, report finds
Twenty people who used umbilical cord blood-derived products marketed as stem cell therapies at clinics across the United States developed serious bacterial infections, a report published by JAMA Network Open found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 7, 2021 Category: Consumer Health News Source Type: news

$6.2 million NIH grant to support UCLA study of how COVID-19 causes multiple organ failure
Researchers from the  Eli and Edythe Broad Center of  Regenerative Medicine and Stem Cell Research at UCLA have received a $6.2 million grant from the National Institutes of Health to study how the SARS-CoV-2 virus causes damage throughout the body.The Director ’s Transformative Research Award was presented through the NIH’s prestigious High Risk, High Reward program, which supports creative and unconventional approaches to major challenges in biomedical and behavioral research. What makes SARS-CoV-2, the virus that causes COVID-19, so dangerous for some people is that although it is a respi...
Source: UCLA Newsroom: Health Sciences - October 5, 2021 Category: Universities & Medical Training Source Type: news

Losing Your Hair? You Might Blame the Great Stem Cell Escape.
By observing mice hair follicles, scientists discovered an unexpected mechanism of aging. “If I didn’t see it with my own eyes I wouldn't believe it, ” one said. (Source: NYT Health)
Source: NYT Health - October 4, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Hair Stem Cells Research Age, Chronological Rui Yi Nature Aging Northwestern University Source Type: news

Asymmetrex Awarded Grant from ARMI BioFabUSA to Develop Tissue Stem...
Stem cell biotechnology company Asymmetrex has been awarded a Technical Project grant from Advanced Regenerative Manufacturing Institute (ARMI) BioFabUSA. The new grant supports studies by Asymmetrex...(PRWeb October 04, 2021)Read the full story at https://www.prweb.com/releases/asymmetrex_awarded_grant_from_armi_biofabusa_to_develop_tissue_stem_cell_counting_technology_for_cell_biomanufacturing/prweb18225696.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 4, 2021 Category: Pharmaceuticals Source Type: news

US Stem Cell Clinics Boomed While FDA Paused Crackdown
Hundreds of clinics sold unapproved treatments for arthritis, Alzheimer’s, COVID-19 and many other conditions. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - October 1, 2021 Category: American Health Source Type: news

US Stem Cell Clinics Boomed While FDA Paused Crackdown US Stem Cell Clinics Boomed While FDA Paused Crackdown
"The scale of the problem is vastly larger for FDA today than it was at the start."Associated Press (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - September 30, 2021 Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news

US stem cell clinics boomed while FDA paused crackdown
The number of U.S. clinics pushing unproven stem cell procedures has ballooned in recent years (Source: ABC News: Health)
Source: ABC News: Health - September 30, 2021 Category: Consumer Health News Tags: Health Source Type: news

Injection to perk up a man's love life
The theory is that the stem cells - which have the ability to turn into different cells - will replace damaged ones and restore normal blood supply to the area. (Source: the Mail online | Health)
Source: the Mail online | Health - September 27, 2021 Category: Consumer Health News Source Type: news

UCLA Broad Stem Cell Research Center receives $5 million CIRM grant for research training program
TheEli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLAhas been awarded $5 million by the California Institute for Regenerative Medicine, the state ’s stem cell agency, to train young scientists and physicians to become leaders in the stem cell and regenerative medicine field.The five-year grant will enable the center to expand its Stem Cell Training Program, which was established in 2006 and funded by CIRM until 2015, when the agency changed its funding priorities. Since then, the program has been sustained by philanthropy. With the passage of Proposition 14 last fall, however, CIRM ha...
Source: UCLA Newsroom: Health Sciences - September 23, 2021 Category: Universities & Medical Training Source Type: news

Harvard professor launches stem cell startup with $72M
One platform, 70 diseases and $72 million — these underpin the launch of Garuda Therapeutics, a new stem cell startup founded by Harvard professor Dhvanit Shah. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 23, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Science Saturday: A fountain of youth for aging muscles
Regenerative medicine could hold the keys to rejuvenating older muscles, and research supporting that will be featured at the Mayo Clinic Symposium on Regenerative Medicine and Surgery. Preclinical research by Helen Blau, Ph.D., Stanford University School of Medicine, discovered a protein that triggers muscle loss and a way to block it to restore youthful muscle strength. Dr. Blau, director of the Baxter Laboratory for Stem Cell Biology at Stanford University School of Medicine, will present her research in a virtual… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - September 18, 2021 Category: Research Source Type: news

Call for South Asian bone marrow donors to save four-year-old
Esha Nadeswaran from London has leukaemia and needs a stem cell donor to save her life. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 14, 2021 Category: Consumer Health News Source Type: news

85% of stem cell transplant recipients develop high antibody levels after two vaccine doses
Researchers from Nantes University Hospital found that people who receive stem cell transplants are likely to develop high antibody responses to the COVID-19 vaccines, even after only one shot. (Source: the Mail online | Health)
Source: the Mail online | Health - September 14, 2021 Category: Consumer Health News Source Type: news

Covid US: At least 1,700 health care workers in San Diego County have filed for vaccine exemptions
At least 1,700 healthcare workers in San Diego County have asked for COVID-19 vaccine mandate exemptions due to religious reasons with most surrounding stem cell picks. (Source: the Mail online | Health)
Source: the Mail online | Health - September 13, 2021 Category: Consumer Health News Source Type: news

ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
SAN DIEGO, Sept. 13, 2021 -- (Healthcare Sales & Marketing Network) -- ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, today announced the appointment of Timothy Kieffer, Ph.D., as Chief Scientific Officer. Dr. Kieffer will brin... Regenerative Medicine, Personnel ViaCyte, cell therapy, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 13, 2021 Category: Pharmaceuticals Source Type: news

Stem cell firm that partners with Duke University grabs space in Durham
A Florida-based biomedical firm has unveiled plans to launch its first clinic in Durham after buying a location in Durham. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 10, 2021 Category: Biotechnology Authors: Caleb Harshberger Source Type: news

Stem cell firm that partners with Duke University grabs space in Durham
A Florida-based biomedical firm has unveiled plans to launch a clinic in Durham. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 10, 2021 Category: American Health Authors: Caleb Harshberger Source Type: news

What Is Stem Cell Research
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 24, 2021 Category: General Medicine Source Type: news

Scientists develop brain organoids with complex neural activity
Researchers at the  Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have developed brain organoids — 3D brain-like structures grown from human stem cells — that show organized waves of activity similar to those found in living human brains.Then, while studying organoids grown from stem cells derived from patients with the neurological disorder Rett syndrome, the scientists were able to observe patterns of electrical activity resembling seizures, a hallmark of the condition.The study, published today in the journal Nature Neuroscience, broadens the list of brain...
Source: UCLA Newsroom: Health Sciences - August 23, 2021 Category: Universities & Medical Training Source Type: news

Wearable Monitors Facilitate Exercise in HSCT Patients Wearable Monitors Facilitate Exercise in HSCT Patients
Could wearable activity monitors help promote and increase physical activity among stem cell transplant patients?Exercise and Sport Sciences Reviews (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2021 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Digested week: I emerge from my soundproof box to more news of idiots | Lucy Mangan
This week ticketless Bravehearts ‘seize’ Edinburgh Castle and scientists grow a Raab replacement in the labToday I disappeared into a lightless, windowless, soundproofed room, four or five feet square, with nothing but myself and a book for company for three days. This would be a lifetime ’s ambition fulfilled were it not for the fact the book is one I wrote and I am in this foam-lined oubliette in order to read it aloud while a man in the next room along records it for publishing-in-audiobook-form purposes.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 20, 2021 Category: Science Authors: Lucy Mangan Tags: UK news Audiobooks Edinburgh Dominic Raab Politics Stem cells Fertility problems Science Source Type: news

Building Better Organoids
Explore tissue-specific protocols for growing organoids from primary tissue or stem cells. (Source: The Scientist)
Source: The Scientist - August 17, 2021 Category: Science Tags: The Marketplace Source Type: news

Selma Blair says she's 'in remission' from multiple sclerosis: 'My prognosis is great'
Selma Blair said it's a result of undergoing hematopoietic stem-cell transplantation. (Source: Reuters: Health)
Source: Reuters: Health - August 16, 2021 Category: Consumer Health News Source Type: news

Researchers identify method for improving health of lab-grown stem cells
Researchers at the University of California San Diego have developed a way to keep lab-grown cells healthy for longer periods of time, they said in an article published Thursday by Cell Stem Cell. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 12, 2021 Category: Consumer Health News Source Type: news

Health Canada says Cord Blood Bank of Canada removed all samples from storage before surprise inspection
A Toronto company that was paid to store potentially life-saving stem cells from the children of roughly 3,000 clients across Canada removed the samples from storage before providing Health Canada access to its lab to conduct a surprise inspection last week, according to the federal department. (Source: CBC | Health)
Source: CBC | Health - August 12, 2021 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

Science Saturday: Regenerative pipeline for spinal cord repair
Mayo Clinic  research is learning how stem cell therapy can treat neurodegenerative diseases. Mayo is among the first to study whether stem cell therapy might trigger healing for spinal cord injury. Research is ongoing in preclinical models, but it also has advanced from discovery science to early clinical tr ials. It's a complex question because different forms of stem cells can be derived from different biologics within the body. Mayo Clinic's Center for Regenerative Medicine is driving the research that… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 31, 2021 Category: Databases & Libraries Source Type: news

Eliminating RNA-binding protein improves survival in aggressive leukemia
Removing a protein that is often overexpressed in a rare and aggressive subtype of leukemia can help to slow the cancer ’s development and significantly increase the likelihood of survival, according to a study in mice led by scientists at theUCLA Jonsson Comprehensive Cancer Center.The research,published today in the journal Leukemia, could aid in the development of targeted therapies for cancers that have high levels of the RNA-binding protein IGF2BP3 — especially acute lymphoblastic and myeloid leukemias that are characterized by chromosomal rearrangements in the mixed lineage leukemia (MLL) gene.In these ML...
Source: UCLA Newsroom: Health Sciences - July 29, 2021 Category: Universities & Medical Training Source Type: news

COVID-19 rapid guideline: haematopoietic stem cell transplantation, NICE (updated 22nd July 2021)
The purpose of this guideline is to maximise the safety of patients who need haemopoietic stem cell transplantation and make the best use of NHS resources, while protecting staff from infection. On 22 July 2021, we made changes to recommendations on testing patients for viruses, including SARS-CoV-2 and repeating respiratory review in patients who test positive for, or are suspected of having COVID-19. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 26, 2021 Category: Consumer Health News Source Type: news

Cardio-cerebrovascular disease history complicates hematopoietic cell transplant outcomes
(Cactus Communications) Transplanting hematopoietic stem cells to treat cancers and other conditions carries with it the risk of developing cardio-cerebrovascular diseases (CCVD)--disorders affecting the blood vessels of the heart and brain. Although research on post-transplant CCVD is extensive, there is paucity of knowledge on the effects of pre-transplant CCVD on transplant outcomes. Now researchers in China suggest pre-transplant CCVD indirectly affects patient mortality and survival following transplant through their strong association with post-transplant CCVD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Perfecting collagen production in osteogenesis imperfecta
(Medical University of South Carolina) Mesenchymal stem cells are the origin for osteoblasts, but MSC transplantation has not resulted in long-term success as a treatment option for brittle bone disease. Hematopoietic stem cells usually give rise to blood cells and osteoclasts, but researchers hypothesized that they could give rise to osteoblasts too. By replacing osteoblasts, they offer a potential therapeutic opportunity that is not dependent on a specific mutation but simply on a mutation being present, which gives patients hope. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Beyond stem cells, regenerative medicine finds exosomes
Exosomes, a new tool in regenerative research, have implications for cardiac and tendon regeneration, wound healing, and incontinence, as well as many other applications. _______________________________ In the 60 or so years since stem cells were first defined, they've become heralds of a new type of medicine, one that promises to harness the body's healing properties. Stem cells are a sort of cellular blank slate and can be engineered to form any cell in the body.… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 22, 2021 Category: Databases & Libraries Source Type: news

A substance from Saussurea controversa will help bone tissue regeneration
(Immanuel Kant Baltic Federal University) Scientists from the IKBFU with colleagues obtained calcium chelidonate via a semisynthesis. This substance accelerates the transformation of stem cells into osteoblasts - its use is promising as a treatment for bone diseases. A plant, Saussurea controversa, used in medicine since ancient times, served as a source for synthesis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2021 Category: International Medicine & Public Health Source Type: news

Secrets and pies: the battle to get lab-grown meat on the menu
Sustainable alternatives to livestock farming are being held back by patents, a reluctance to share research and lack of government supportNot a week goes by without Elliot Swartz receiving at least one request from researchers asking him where they can find cell lines (a cell culture developed from a single cell) for use in cellular agriculture – an essential tool for creating lab-grown meat. “One of the most important things that cell lines offer is that they enable researchers to just get started in this new field,” says Swartz, who works in New York as a senior scientist at theGood Food Institute (GFI...
Source: Guardian Unlimited Science - July 18, 2021 Category: Science Authors: Jack McGovan Tags: Stem cells Biology Research and development Meat industry Food Technology Science Source Type: news

Ruxolitinib Best Option When Glucocorticoids Fail Against Chronic GVHD Ruxolitinib Best Option When Glucocorticoids Fail Against Chronic GVHD
When chronic graft-versus-host disease follows an allogeneic stem-cell transplant, and it's either resistant to standard glucocorticoid therapy or dependent on glucocorticoids, according to the REACH3 trial.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 16, 2021 Category: Transplant Surgery Tags: Allergy & Clinical Immunology News Source Type: news

3D " assembloid " shows how SARS-CoV-2 infects brain cells
(University of California - San Diego) Researchers at UC San Diego School of Medicine and Rady Children's Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus that causes COVID-19, into the human brain. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 16, 2021 Category: Biology Source Type: news

Mesenchymal Stem Cells in COVID-19 Mesenchymal Stem Cells in COVID-19
Might mesenchymal stem cells have a therapeutic role in critically ill patients suffering from COVID-19? This paper looks at the current state of research.Laboratory Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2021 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Pierre Vanderhaeghen awarded for his pioneering research
(Spanish National Research Council (CSIC)) The jury of the 10th edition of the Remedios Caro Almela Prize for Research in Developmental Neurobiology has decided to award this prize to Pierre Vanderhaeghen, director of the stem cell and developmental neurobiology laboratory of the VIB-KU Leuven Center for Research on the Brain and its Diseases (Belgium). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 14, 2021 Category: Biology Source Type: news

Regulatory Affairs Expert Ana Sousa Joins Aspen Neuroscience as Senior Vice President
SAN DIEGO, July 13, 2021 -- (Healthcare Sales & Marketing Network) -- Aspen Neuroscience, Inc., a private biotechnology company developing the first autologous neuron replacement therapies to treat Parkinson's disease (PD), announced today that Ana Sousa ... Regenerative Medicine, Neurology, Personnel Aspen Neuroscience, Parkinson, stem cell (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 13, 2021 Category: Pharmaceuticals Source Type: news

Sensing " junk " RNA after chemotherapy enhances blood regeneration
(Max Planck Institute of Immunobiology and Epigenetics) Scientists from the MPI-IE reveal that during hematopoietic regeneration, RNA expressed from a part of the genome considered " junk DNA " is used by hematopoietic stem cells to get activated and proliferate. The study published in the scientific journal Nature Cell Biology shows that these so-called transposable elements make RNA after chemotherapy and activate an immune receptor which induces inflammatory signals enhancing hematopoietic stem cell cycling and thus participating in the regeneration of the hematopoietic system. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2021 Category: International Medicine & Public Health Source Type: news

Euro 2020: Man missed England win to donate stem cells
Sam Astley's partner won tickets but he says there was "no way" he was going to delay the donation. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 8, 2021 Category: Consumer Health News Source Type: news

Mayo Clinic Minute: Why bone marrow donor diversity is needed
Bone marrow transplants are procedures that infuse healthy blood stem cells into your body to replace damaged or diseased bone marrow. Just like people in need of solid organ transplants, such as hearts or kidneys, people in need of a bone marrow transplant have to find a matching donor. Dr. Ernesto Ayala, a Mayo Clinic hematologist and oncologist, says bone marrow donations from people of all races and ethnicities are essential in order to help… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 8, 2021 Category: Databases & Libraries Source Type: news

Thomas Rando named director of UCLA Broad Stem Cell Research Center
Dr. Thomas Rando, a renowned neurologist and stem cell biologist, has been named director of the  Eli and Edythe Broad Center of  Regenerative Medicine and Stem Cell Research at UCLA.Rando, who was chosen after an international search, is currently a professor of neurology and neurological sciences at the medical school at Stanford University, where he also serves as director of the Glenn Center for the Biology of Aging and deputy director of the Stanford Center on Longevity. In addition, he is chief of neurology at the  Veterans Affairs Palo Alto Health Care System.His appointment is effective Oct. 1.&ldquo...
Source: UCLA Newsroom: Health Sciences - July 7, 2021 Category: Universities & Medical Training Source Type: news

Uncovering the genetic mechanism behind Rett syndrome
(Kyushu University) Kyushu University researchers found that the main gene that causes Rett syndrome, MeCP2, controls the differentiation pattern of neural stem cells through the microRNA miR-199a. Dysfunction in MeCP2 or miR-199a cause neural stem cells to produce more astrocytes than neurons. Furthermore, the researchers found that miR-199a mediates the production of Smad1, a downstream transcription factor of bone morphogenetic protein (BMP) signaling. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 2, 2021 Category: International Medicine & Public Health Source Type: news

NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Summer 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR to Release Report on Oral Health in America As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news

From meadow to plate: The cultured meat that replaces animals with grass
(University of Bath) An affordable lab system that uses grass blades to turn cells into cultured meat, by creating a scaffold that animal stem cells can attach to and grow on, has been developed at the University of Bath in the UK. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 1, 2021 Category: Biology Source Type: news

Stem Cell Transplant Treats Parkinson & rsquo;s Disease in Monkeys
(Source: The Scientist)
Source: The Scientist - July 1, 2021 Category: Science Tags: Sponsored Article Source Type: news